Showing results (211-220 of 667) with videos related to
Sort By:
Pageof 67
Revue D'Epidemiologie Et De Sante Publique|January 1, 1981
Met and unmet demand for hospital beds. Some recent evidenceJ G Cullis, D P Foster, C E FrostBiochemistry|January 11, 2007
Solution NMR of large molecules and assembliesMark P Foster, Craig A McElroy, Carlos D AmeroAdvanced Drug Delivery Reviews|June 12, 2004
Sustained release veterinary parenteral productsNatalie J Medlicott, Niki A Waldron, Todd P FosterVirus Research|May 29, 2012
HSV-2 inhibits type-I interferon signaling via multiple complementary and compensatory STAT2-associated mechanismsRavi-Kumar Kadeppagari, Rebecca L Sanchez, Timothy P FosterJournal of Virological Methods|November 1, 2011
Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopesRebecca L Sanchez, Alistair J Ramsay, Timothy P FosterJournal of Chemical Ecology|November 22, 2013
Behavioral responses of male epiphyasPostvittana (walker) to sex pheromone-baited delta trap in a wind tunnelS P Foster, S J Muggleston, R D BallJournal of Virology|November 17, 2001
Glycoprotein K specified by herpes simplex virus type 1 is expressed on virions as a Golgi complex-dependent glycosylated species and functions in virion entryT P Foster, G V Rybachuk, K G KousoulasVirology|August 16, 2001
An alpha-helical domain within the carboxyl terminus of herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) is associated with cell fusion and resistance to heparin inhibition of cell fusionT P Foster, J M Melancon, K G KousoulasAntiviral Research|May 19, 2016
Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathwaysMaria Dulfary Sanchez, Augusto C Ochoa, Timothy P FosterDrugs|January 28, 2025
Emerging Immunotherapies for Disease Modification of Type 1 DiabetesTimothy P Foster, Brittany S Bruggeman, Michael J HallerPageof 67